Unknown

Dataset Information

0

Intradermal delivery of modified mRNA encoding VEGF-A in patients with type 2 diabetes.


ABSTRACT: Chemically modified mRNA is an efficient, biocompatible modality for therapeutic protein expression. We report a first-time-in-human study of this modality, aiming to evaluate safety and potential therapeutic effects. Men with type 2 diabetes mellitus (T2DM) received intradermal injections of modified mRNA encoding vascular endothelial growth factor A (VEGF-A) or buffered saline placebo (ethical obligations precluded use of a non-translatable mRNA control) at randomized sites on the forearm. The only causally treatment-related adverse events were mild injection-site reactions. Skin microdialysis revealed elevated VEGF-A protein levels at mRNA-treated sites versus placebo-treated sites from about 4-24?hours post-administration. Enhancements in basal skin blood flow at 4?hours and 7 days post-administration were detected using laser Doppler fluximetry and imaging. Intradermal VEGF-A mRNA was well tolerated and led to local functional VEGF-A protein expression and transient skin blood flow enhancement in men with T2DM. VEGF-A mRNA may have therapeutic potential for regenerative angiogenesis.

SUBMITTER: Gan LM 

PROVIDER: S-EPMC6382754 | biostudies-literature | 2019 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications


Chemically modified mRNA is an efficient, biocompatible modality for therapeutic protein expression. We report a first-time-in-human study of this modality, aiming to evaluate safety and potential therapeutic effects. Men with type 2 diabetes mellitus (T2DM) received intradermal injections of modified mRNA encoding vascular endothelial growth factor A (VEGF-A) or buffered saline placebo (ethical obligations precluded use of a non-translatable mRNA control) at randomized sites on the forearm. The  ...[more]

Similar Datasets

| S-EPMC4415018 | biostudies-literature
| S-EPMC3594035 | biostudies-literature
| S-EPMC5474881 | biostudies-other
| S-EPMC3173582 | biostudies-other
| S-EPMC10013810 | biostudies-literature
| S-EPMC7369517 | biostudies-literature
| S-EPMC6352505 | biostudies-literature
| S-EPMC8152636 | biostudies-literature
| S-EPMC10146866 | biostudies-literature
2023-10-20 | E-MTAB-13381 | biostudies-arrayexpress